Company news
Plandai Biotechnology, Inc. (OTC:PLPL) news
Plandai Biotechnology, Inc. news releases on 6ix. Latest, May 19, 2023: Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck…
Press releases & updates
Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health
May 18, 2023
Following Completed Share Exchange Agreement with ByoPlanet, Plandai Announces Material Rebranding to Disinfectant Industry Focus
May 17, 2023
ByoPlanet Announces Completion of Share Exchange Agreement with Plandai Biotechnology
May 16, 2023
Plandai Biotechnology, Inc. Announces Entry into Material Share Exchange Agreement with Good Salt, LLC
March 19, 2023
Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit
January 3, 2023
EV Hotel Corp. and Plandai Biotechnologies Enter Into Asset Acquisition Agreement to Create the Leading Smart Hotel Brand - EV Hotel Corp.
November 7, 2022
Plandai Biotechnologies, Inc. Announces Entry into Non-Binding Letter of Intent, Updates on Status of Independent Audit
October 5, 2022
Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
July 26, 2022
SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action
June 21, 2022
Plandai Biotechnology In Non-Binding Letter of Intent to Acquire Rights to Puriblood’s Leukocyte Reduction Blood Filtration System with Plans to Address the International Blood Filtration Market
May 22, 2022
Plandai Biotechnologies, Inc. Announces Resolution on Final Legacy Debt with EMA Financial in Private Transaction with Accredited Investor
January 30, 2022
Plandai Announces Cancellation and Release of Legacy Debt
December 8, 2021
SEC Litigation Release
August 1, 2018
Plandai Biotechnology Exploring Opportunities in the U.S. Poultry Market
July 3, 2018
Plandaí Biotechnology to Focus on International Nutraceutical Cannabis Opportunities
June 19, 2018
Plandai Biotechnology Discusses Cannabis Extract Opportunities and Research Potential
June 14, 2018
Plandai Biotechnology Discusses Potential for Using Phytofare in Treating Type II Diabetes
June 12, 2018
Plandai Biotechnology’s SORBEO Phytofare Reports Positive Results in Chicken Studies
May 30, 2018
Plandai Biotechnology Announces Origine 8 Wins Prestigious Natural & Organic Products Award
May 24, 2018
Plandai Biotechnology’s Phytofare® Green Tea Catechins as a Phytogenic Substance in Poultry Diets
May 22, 2018
Plandai Biotechnology Addresses Opportunities in the South African and Global Poultry Industries
May 16, 2018
Plandai Biotechnology’s Phytofare Gaining Traction in International Markets
May 9, 2018
Plandai Biotechnology’s Phytofare® Utilizes Green Tea to Fight Type 2 Diabetes
May 3, 2018
Plandai Biotechnology Appoints Paritz & Company as New Auditor
March 27, 2018
Plandai Biotechnology Issues Business Targets and Milestones for Remainder of 2018
March 20, 2018
Plandai Biotechnology Engages Hayden IR to Develop Comprehensive Investor Relations Program
March 12, 2018
Plandai Biotechnology Ships 1.2 Million Origine 8 Capsules to Coyne Healthcare
May 22, 2017
Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes
May 18, 2017
Plandai Biotechnology Announces Phytofare to Be Focus of Human Clinical Trial for Type II Diabetes in Mauritius
May 16, 2017
Plandaí Biotechnology Changing the Future of Green Tea with Technology Used in Origine 8 Capsules
May 10, 2017
Plandai Biotechnology Executes Exclusive Distribution Agreement With Cambridge Commodoties for UK and All of Europe
May 8, 2017
Plandai Biotechnology Expanding Footprint of Phytofare into U.S. with Continued Sales
May 4, 2017
Plandai Biotechnology Receives 1.2 Million Origine 8 Capsule Order From Coyne Healthcare
May 2, 2017
Plandai Biotechnology Names Ezra Jones as Vice President of Sales and Marketing
April 28, 2017
Plandai Biotechnology Gains Credibility with NutriBullet Deal
April 26, 2017
NutriBullets SuperFood Boost Featuring Plandai Biotechnology's Phytofare Expected to Hit Retailers in May
April 24, 2017
Plandai Biotechnology Sets Aggressive Agenda for 2017
April 19, 2017
Plandai Biotechnology New Chief Operating Officer Provides Outlook and Milestones for 2017
April 17, 2017
Plandai Biotechnology, Inc. Gives Annual Report of Progress and Provides Projections for 2016
December 28, 2015
Plandai Biotechnology, Inc. Reaches Agreement With Deltamune to Study Commercial Potential of Phytofare in Livestock
November 18, 2015
Plandai Biotechnology, Inc. Announces Distribution Agreement With Bal Pharma Ltd Covering India
October 29, 2015
Plandai Biotechnology, Inc. Announces USN Developing New Products Using Phytofare(R)
August 26, 2015
Plandai Biotechnology, Inc. Announces Expansion of Agreement With USN to Now Include the European Union
August 10, 2015
Plandai Biotechnology, Inc. Continues to Deliver Green Tea Extract to USN
July 15, 2015
Plandai Biotechnology Enters Into Agreement to Supply Phytofare to United Kingdom Distributor With First Purchase Order
June 29, 2015
Plandai Biotechnology's Phytofare(R) Catechin Complex Hits the Shelves With New USN Label
June 18, 2015
Plandai Biotechnology, Inc. Delivers on First Purchase Order of Green Tea Extract to USN
May 21, 2015
Plandai Biotechnology, Inc. Receives First Purchase Order in Exclusive Supplier Agreement With USN
May 13, 2015
Plandai Biotechnology, Inc. Signs Agreement to Become Exclusive Supplier to USN
May 11, 2015
New Video Documents Plandai Biotechnology's $20 Million Operation at Senteeko Tea Estate
April 14, 2015